[F-18] Fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases
Article first published online: 24 NOV 2003
Copyright © 2003 Wiley-Liss, Inc.
Journal of Surgical Oncology
Volume 84, Issue 4, pages 215–223, December 2003
How to Cite
Donckier, V., Van Laethem, J. L., Goldman, S., Van Gansbeke, D., Feron, P., Ickx, B., Wikler, D. and Gelin, M. (2003), [F-18] Fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. J. Surg. Oncol., 84: 215–223. doi: 10.1002/jso.10314
- Issue published online: 24 NOV 2003
- Article first published online: 24 NOV 2003
- Manuscript Accepted: 24 SEP 2003
- RadioTherapeutics Corp. (a research grant for clinical study and data management)
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.